Learn more

THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY

Overview
  • Total Patents
    21
About

THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY has a total of 21 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SUZHOU CONNECT BIOPHARMACEUTICALS LTD, BELLICUM PHARMACEUTICALS INC and PROYECTO DE BIOMEDICINA CIMA S L.

Patent filings in countries

World map showing THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARYs patent filings in countries
# Country Total Patents
#1 Australia 21

Patent filings per year

Chart showing THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Dimitrov Dimiter S 4
#2 Zhang Mei-Yun 3
#3 Boyd Michael R 3
#4 Gustafson Kirk R 2
#5 Brechbiel Martin W 2
#6 Pavlakis George N 2
#7 Chong Hyun-Soon 2
#8 Felber Barbara K 2
#9 Kim Hyun K 1
#10 Mckee Tawnya C 1

Latest patents

Publication Filing date Title
AU2004233464A1 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
AU2003270347A1 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same
AU2003248545A1 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
AU2003237187A1 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries
AU2003239356A1 Identification of novel broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies
AU2003226141A1 Method for treating cancer in humans
AU2002337885B1 Broadly cross-reactive neutralizing antibodies against human ummunodeficiency virus selected by Env-CD4-co-receptor complexes
AU2002326957B2 Transductin-1 and transductin-2 and applications to hereditary deafness
AU2002236526B2 Sol-fusin: use of GP64-6His to catalyze membrane fusion